Long-term prophylactic treatment with deucrictibant for angioedema due to acquired C1-inhibitor deficiency
Deucrictibant extended-release tablet effectively prevented angioedema attacks in patients with AAE-C1INH, with no safety concerns.
Authors
- Remy S. Petersen (ORCID: https://orcid.org/0000-0003-4836-7349)
- Danny M. Cohn
- Lauré M. Fijen (ORCID: https://orcid.org/0000-0002-0834-8138)
- M. Lange
Institutions
- Amsterdam Neuroscience (NL)
- Amsterdam University Medical Centers (NL)
- Amsterdam University of Applied Sciences (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1016/j.jaci.2025.07.033
- Citations
- 4
- Primary Topic
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Type
- article
- Field-Weighted Citation Impact
- 6.50